Howdy
We're a medical device company that will soon transition from R&D to testing of our medical device components/assemblies. The FDA requires that our test samples are "representative of the final product". But we have a very expensive circuit board, sealed inside of our medical device, and it's not actually relevant to most of our testing (biocompatibility, cleaning, sterilization).
So we will make a separate "non-functional" model that is the same shell, but no guts inside (no expensive circuit board) to use for these kinds of testing. Our real/functional medical device goes through our change control process and is assigned an document ID number and a version number. So should this fake "non-functional" model also go through our change control process to get a separate document ID number and version number?
In my mind, we could either A) put the "nonfunctional" model through our change control too, or B) don't do that but instead write any explanation of differences in the separate test protocol documents for biocompatibility testing, cleaning testing, sterilization testing, etc.
Any input would be appreciated. Thank you!

So we will make a separate "non-functional" model that is the same shell, but no guts inside (no expensive circuit board) to use for these kinds of testing. Our real/functional medical device goes through our change control process and is assigned an document ID number and a version number. So should this fake "non-functional" model also go through our change control process to get a separate document ID number and version number?
In my mind, we could either A) put the "nonfunctional" model through our change control too, or B) don't do that but instead write any explanation of differences in the separate test protocol documents for biocompatibility testing, cleaning testing, sterilization testing, etc.
Any input would be appreciated. Thank you!